Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity Transcript
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to seekingalpha.com, company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President, CEO & Director Erik Ingelsson - Chief Scientific Officer Christopher Wright - Chief Medical Officer Conference Call Participants Steven Seedhouse - Cantor Fitzgerald & Co., Research Division Joseph Schwartz - Leerink Partners LLC, Research Division Cheng Li - Oppenheimer & Co.
Sources
1
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/wave-life-sciences-slips-obesity-140035664.html
2
Seeking Alpha Market News
https://seekingalpha.com/article/4886339-wave-life-sciences-ltd-wve-discusses-positive-interim-phase-i-data-from-inlight-trial-of?source=feed_all_articles